Molindone
- Generic Name
- Molindone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H24N2O2
- CAS Number
- 7416-34-4
- Unique Ingredient Identifier
- RT3Y3QMF8N
- Background
An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alph...
- Indication
Molindone is used for the management of the manifestations of psychotic disorders.
- Associated Conditions
- Schizophrenia
- Associated Therapies
- -
Open-Label, Extension Study to 810P202
- Conditions
- Interventions
- First Posted Date
- 2011-08-12
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Supernus Pharmaceuticals, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT01416064
Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
- Conditions
- Interventions
- First Posted Date
- 2003-02-05
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 116
- Registration Number
- NCT00053703
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸Cambridge Health Alliance, Medford, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.